Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05362968 · ClinicalTrials.gov registry record · Phase 1
Strawberries and Risk of Diabetes in Adults
A Phase 1 study, sponsored by University of Nevada, Las Vegas.
- Completed
- Registry status
- Phase 1
- Development phase
- 39
- Enrollment target
NCT05362968: Completed Phase 1 study, sponsored by University of Nevada, Las Vegas.
NCT05362968 is a Phase 1 study that has completed, run by University of Nevada, Las Vegas. The registered enrollment target is 39 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (35% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05362968, a Phase 1 study, has completed, sponsored by University of Nevada, Las Vegas.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 39 participants
- Enrollment target
Study Summary
Strawberries can be categorized as a functional food based on results from several clinical trials in improving cardiometabolic health beyond providing nutrition. Recent studies identify the role of strawberries in improving insulin resistance and risks of type 2 diabetes which urgently warrants further investigation, keeping in view the huge public health burden of diabetes in the US. In this study, the investigators propose to investigate the effects of a dietary achievable dose of strawberries on glycemic control, insulin resistance, and HbA1c (primary variables) and biomarkers of inflammation and endothelial function in a 28- week controlled crossover study.
Primary Outcome
Blood glucose, insulin, glycated hemoglobin
Interventions
- DRUG Freeze-dried strawberry powder
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 39 participants |
| Start Date | 2023-01-01 |
| Est. Completion | 2024-06-03 |
| Phase | Phase 1 |
What the finished NCT05362968 record still lists
NCT05362968 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 39 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (35% lower).
The record links to 0 conditions, and to 1 intervention - of which Freeze-dried strawberry powder is the first listed.
NCT05362968 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05362968 about?
NCT05362968 is a clinical study titled "Strawberries and Risk of Diabetes in Adults". Strawberries can be categorized as a functional food based on results from several clinical trials in improving cardiometabolic health beyond providing nutrition. Recent studies identify the role of strawberries in improving insulin resistance and risks of type 2 diabetes which urgently warrants fur...
What is the current status of trial NCT05362968?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 39 participants. The study started on 2023-01-01. Estimated completion is 2024-06-03.
What interventions are being tested in trial NCT05362968?
The interventions under investigation include: Freeze-dried strawberry powder (DRUG).
Who is sponsoring clinical trial NCT05362968?
This trial is sponsored by University of Nevada, Las Vegas, which has 52 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05362968's enrollment target sits among peer trials
39 1191st of 2000 higher than 804 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03465592 · 39 participants · Phase 1
Trial of Nivolumab Following Partially Human Leukocyte Antigen (HLA) Mismatched BMT in Children & Adults With Sarcoma
- NCT03961776 · 39 participants
Monitoring Treatment Response With On-board DWI During Neo-adjuvant Chemo-radiation for Rectal Cancer Using Magnetic Resonance-guided-radiotherapy Systems
- NCT04050280 · 39 participants · Phase 2
CLAG-GO for Patients With Persistent, Relapsed or Refractory AML
- NCT04190862 · 39 participants · Phase 1
E-CEL UVEC as an Adjunct Cell Therapy for Treatment of Anal Fistulas
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI